Scenario calculator
Price target (simple) needs positive TTM EPS. Try Advanced (revenue) mode when earnings are negative.
Enter EPS growth and exit P/E per scenario. The chart starts at the current share price (Now) and transitions the P/E from today's trailing multiple toward your Exit P/E over the horizon. Same live price and TTM EPS as the rest of the page.
Annual diluted EPS
GAAP diluted earnings per share by fiscal year (from reported statements). Use it as context for the EPS growth assumptions in the scenario calculator above — not a forecast.
Across 9 fiscal years, diluted EPS went from about $-0.85 in 2017 to about $-5.95 in 2025.
Scale: -5.95 to 0.00 EPS; horizontal line at 0. Fiscal years with no row in the database are omitted.
Historical multiples
Each bar is the trailing five-year range (low left, high right). Gray fill from low to today; dot = today; amber tick = median. Low, median, and high are listed under each bar.
Net cash
$0.2B
Beta
1.41
Vs market benchmark
Return drivers (illustrative)
Historical EPS growth and where today’s P/E sits vs its five-year median — same P/E basis as the scenario price paths chart above.
Not enough history on this page to show EPS growth or median P/E context.
Frequently asked questions
How is RVMD's price target calculated?
Price targets here use projected EPS × exit P/E. Future EPS = TTM EPS × (1 + growth)^years, then price = future EPS × P/E. The tool pre-fills analyst consensus and historical ranges for Revolution Medicines (RVMD) so you can compare your assumptions to the data.
What is RVMD's base-case price target?
With about 10% annual EPS growth and a 20× exit P/E over 5 years based on consensus from 16 analysts, the base case for Revolution Medicines (RVMD) lands near $-229.01, implying roughly 0.0% CAGR. This is illustrative, not a forecast.
What P/E ratio should I use for RVMD?
Defaults use 5-year median P/E for the base case, the 25th percentile for bear and the 75th for bull. Adjust the Exit P/E sliders if you have a different valuation view.
What is RVMD's expected return in this model?
Expected return depends on your assumptions. The calculator reports CAGR = (Future price / Current price)^(1/Years) − 1. This is illustrative only and not investment advice.
What time horizon does the price target use?
The default horizon is 5 years; you can change it from 1 to 10 years. Longer horizons compound EPS growth and re-rating effects more strongly, so total returns become more sensitive to assumptions.
Is this a recommendation to buy or sell RVMD?
No. The price-target calculator is an educational tool that turns explicit growth and P/E assumptions into a model price. Peers in the Healthcare sector are listed below for context. It is not investment advice and does not predict future returns.
Explore more
RVMD Overview
Company profile, financial tools, and key metrics
RVMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RVMD How It Makes Money
Discover visual breakdown — where revenue comes from and where it goes.
RVMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RVMD Daily Price Character
Explosive · 50.7% historical win rate (green days). Streaks & record days.
RVMD Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
RVMD Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.